ArticleFrontiers in physiology2025
Exploring the impact of individual components of the Life's Essential 8 on the relationship between atherogenic index of plasma and adverse cardiovascular events: a population-based cohort study in China.
Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The American Heart Association (AHA) recently emphasized the significance of the "Life's Essential 8" in promoting cardiovascular health. The Atherogenic Index of Plasma (AIP) is increasingly recognized as a valuable alternative biomarker for cardiovascular diseases (CVD) and insulin resistance-related metabolic diseases. However, the impact of the individual components of the "Life's Essential 8" on the association between AIP and CVD has not been adequately investigated. Methods: We conducted an analysis of data from 8,246 participants enrolled in the China Health and Retirement Longitudinal Study. Lifestyle behaviors and health factors were classified into binary or tertiary categories according to risk levels. We employed multivariate logistic regression and smooth curve fitting techniques to investigate the association between AIP and CVD across varying groups of health behaviors and factors. Additionally, Receiver Operating Characteristic (ROC) curve analysis was utilized to assess the predictive value of combining healthy behaviors, factors, and AIP in forecasting the incidence of CVD. Results: Upon adjusting for established cardiovascular risk factors, elevated AIP levels correlated with a heightened CVD risk (odds ratio [OR], 1.36; 95% confidence interval [CI], 1.29-1.43). Significant interactions between AIP and CVD risk were observed across subgroups differentiated by blood glucose levels, low-density lipoprotein cholesterol (LDL-C), and sleep duration (P for interaction <0.05). Notably, individuals with blood glucose levels ≥6.1 mmol/L (OR, 1.44; 95% CI, 1.33-1.56) or LDL-C ≥3.12 mmol/L (OR, 1.50; 95% CI, 1.37-1.65) exhibited a more pronounced association between AIP and CVD. Furthermore, the inclusion of AIP in the model alongside traditional risk factors notably enhanced the predictive accuracy for CVD events, as evidenced by an increase in the area under the curve (AUC) from 0.651 to 0.671. Conclusion: Health behaviors (sleep duration), and health factors, including glucose and LDL-cholesterol levels, may modulate the posstive relationship between the AIP and CVD events in middle-aged and elderly individuals. AIP may offer enhanced predictive value for CVD in patients suffering from diabetes or dyslipidemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.